Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900026165Phase 4Recruiting
Phase 4, open-label, single-arm trial of paclitaxel in gastric cancer (GC), sponsored by Affiliated Hospital of Qinghai University. Primary endpoints: CD4 lymphocyte counts in peripheral blood and CD8 lymphocyte counts in peripheral blood. Started Oct 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900026165.